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ABSTRACT 
 
The cases of three children, 16, 12, and 12 years of age, who suffered sudden 
confusional state and cortical blindness lasting 12 to 30 minutes while under treatment 
with high-dose methotrexate, cyclophosphamide, and dactinomycin for a lower limb 
osteosarcoma are reported. Transient neuropsychologic deficits arose after the acute 
phase of treatment: left hemispatial neglect and constructive apraxia (Patient 1); 
constructive apraxia (Patient 2); and constructive apraxia and alexia without aphasia 
(Patient 3). The three patients recovered completely from all their deficits within the 
time frame of 3 hours to 2 weeks. Arterial hypertension and hypomagnesemia were 
found during the acute phase in all patients. In Patients 2 and 3, magnetic resonance 
imaging revealed increased parieto-occipital T2 signal involving gray and white matter. 
In Patients 1 and 2, HmPAO-SPECT revealed parieto-occipital hypoperfusion that 
resolved a few days later. The alterations detected by neuroimaging were concurrent 
with the appearance and disappearance of the clinical symptoms. Such transient acute 
episodes have been named occipital-parietal encephalopathy. On the basis of our 
clinical, laboratory, and neuroimaging findings, an explanation for the origin of this 
syndrome, a migrainelike mechanism, triggered by chemotherapy-induced 
hypomagnesemia, is proposed.  
 
 
 
 
 
 
 
 
INTRODUCTION 
 
Complicated migrainelike episodes during immunosuppressive therapy or antitumoral 
chemotherapy with or without cranial irradiation have been described in adult [1,2] and 
pediatric patients [3,4]. In general the acute clinical features include confusional state, 
loss of vision, headache, and, in many cases, epileptic seizures. Although the 
physiopathology of this syndrome remains unclear, a reversible brain ischemic 
phenomenon has been proposed that could be caused by arterial hypertension, low 
Mg2+/ Ca2+ ratio, and brain microvascular anatomophysiologic changes induced by 
chemotherapy and/or radiotherapy. On the basis of neuroimaging features, the names 
reversible posterior leukoencephalopathy [1] and occipital-parietal encephalopathy [4] 
have been proposed for this syndrome. 
 
Three pediatric patients with osteosarcomas in their legs who suffered episodes of this 
transient encephalopathy during chemotherapy without previous cranial irradiation are 
reported. On the basis of their clinical features, biochemical tests, and 
morphologic/functional neuroimaging, the physiopathology and possible therapeutic 
management of this syndrome are discussed. 
 
 
 
CASE REPORTS 
 
Patient 1 
 
This patient was a 16-year-old male with a fibular osteogenic sarcoma who initially 
received high-dose methotrexate (HDMTX) chemotherapy (T10 Rosen-modified 
protocol) that was discontinued 1 month before completion because of prolonged toxic 
serum levels. The patient was then put on cyclophosphamide and dactinomycin, but 1 
day later he developed an acute confusional state with motor restlessness, dystonic limb 
spasms, and headache, all of which lasted 30 minutes. Then cortical blindness 
developed for several minutes, followed by residual left homonymous hemianopsia and 
hemiparesia; he demonstrated constructive apraxia and partial left hemispatial neglect 
during the copy of the Rey-Osterrieth complex figure. Thirty-six hours later the motor 
and visual hemisyndrome had disappeared entirely, the patient did not present any 
symptoms of visual agnosia or negligence, and his copy of the Rey figure was normal.  
 
His initial blood pressure was 150/90 mm Hg, and his serum total magnesium level was 
1.3 mg/dL (normal range 1.9-2.5 mg/dL). A computed tomography scan did not reveal 
metastasis or other lesions. During the acute stage the electroencephalogram (EEG) was 
characterized by hypersynchronous slow waves. A brain singlephoton emission 
computed tomography (SPECT) using 99mTc-HmPAO (Ceretec, Nycomed-Amershan) 
was obtained and revealed hypoperfusion on the right parieto-temporo-occipital region 
(Fig 1A). Thirty-six hours after initial presentation, when clinical symptoms had 
completely resolved, EEG and a new brain 99mTc-HmPAO SPECT (Fig 1B) revealed no 
abnormality. Treatment was started during the acute phase. Restoration of normal 
magnesium serum levels (1.9-2.4 mg/dL) was achieved in 24 hours after IV perfusion of 
maintenance doses of 3 mg/kg/day of magnesium sulphate. Oral flunarizine (10 mg, 
single dose) and dexamethasone (1 mg/kg per day for 1 week) treatment was initiated. 
 
Patient 2 
 
The second patient was a 12-year-old male with a right femur osteosarcoma who first 
had received IV HDMTX infusion, which was later replaced by a cycle of 
cyclophosphamide, bleomycin, dactinomycin, and vincristine. One week later he 
suddenly presented slurred speech, disorientation, and dystonic posture of his right arm 
with head deviation to the right; this episode lasted for 2-3 minutes. A homonymous left 
hemianopsia was later confirmed in the emergency department, where the patient then 
presented a generalized tonic-clonic seizure that ended 25 minutes later with rectal 
diazepam and a loading dose of IV phenytoin. Hemianopsia resolved in 24 hours. Then 
the patient demonstrated a constructive apraxia with the Rey-Osterrieth complex figure 
test, from which he recovered 2 days later. Blood pressure at admission was 150/100 
mm Hg and serum magnesium level was 1.9 mg/dL, which is at the lower end of the 
normal range. EEG hypersynchronous slow waves were present in the right posterior 
area. Magnetic resonance imaging (MRI) of the brain 2 hours after admission revealed a 
high T1 and T2 corticosubcortical signal on the right temporo-occipital junction. The 
99mTc-HmPAO SPECT 6 hours after the start of symptoms exhibited global hypo-
perfusion of the right cerebral hemisphere, more marked in premotor and temporo-
occipital areas.  
 
Three days later, MRI scan and brain SPECT were completely normal. Maintenance 
oral doses of magnesium lactate (12 mg/kg per day of magnesium element) restored the 
normal serum levels. Oral dexamethasone (1 mg/kg per day) was given for 1 week and a 
single dose of oral flunarizine (10 mg) was given during the acute phase. 
 
 
 
Patient 3 
 
The third patient was a 12-year-old female suffering from a right tibial sarcoma who 
had received her first IV HDMTX cycle followed by cyclophosphamide, dactinomycin, 
bleomycin, and vincristine IV infusion. Six days later, she developed sudden cortical 
blindness and headache with occasional vomiting for 2 hours. These symptoms were 
followed by a generalized tonic-clonic seizure. After recovery, visual agnosia 
developed. Blood pressure was 160/120 mm Hg, serum magnesium level was 1.5 
mg/dL, and serum creatinine was 1.5 mg/dL (normal range is 0.1-1.2 mg/dL).  
 
Subsequently, every 2 weeks the patient underwent neuropsychologic tests that revealed 
constructive apraxia and alexia without aphasia, both of which resolved in 3 months. A 
generalized low-voltage slow rhythm was seen on the EEG. A cerebral MRI scan 
indicated bilateral white and gray matter changes on parieto-temporo-occipital areas, 
more intense on the left side (Fig 2), which disappeared within 3 months. Functional 
neuroimaging was not performed. Treatment with oral magnesium (12 mg/kg per day) 
led to the restoration of normal serum levels within the first 24 hours after admission. 
Dexamethasone (1 mg/kg per day) was given for 1 week. 
 
 
 
 
 
DISCUSSION 
 
Three patients are reported who developed an acute onset of confusional state and 
cortical blindness lasting up to 30 minutes while they were treated with HDMTX, 
cyclophosphamide, and dactinomycin. A similar transient acute encephalopathy has 
been reported as a side effect in patients receiving chemotherapy or immunosuppressive 
treatment [1,2,4]. Despite some evidence of gray matter changes demonstrated by MRI 
scan, the syndrome was termed reversible posterior leucoencephalopathy by Hinchey et 
al. [1]. MR spectroscopy and positron emission tomography (PET) findings reported by 
Pavlakis et al. [4] in children demonstrated neuronal damage, so the term occipital-
parietal encephalopathy, which includes white matter changes and gray matter damage, 
was proposed. We have chosen to refer to this syndrome as posterior encephalopathy. 
 
The mechanisms underlying this condition remain unclear. A hypertensive 
encephalopathy-like mechanism, in addition to the toxic effect of the drugs on the 
endothelium of the blood-brain barrier, has been proposed as a possible explanation by 
Hinchey et al. [1]. They reported a long series in adults and postulated the 
physiopathologic mechanism, but blood pressure was normal in one third of the patients 
included in the study. The arterial pressure values in Patients 1 and 2 of our study give 
little support to this theory because they are far from those values needed to provoke a 
true hypertensive encephalopathy [5]. In addition, brain SPECT has demonstrated 
localized hyperperfusion in subjects suffering from hypertensive encephalopathy [6] in 
contrast to the hypoperfusion found in our patients. 
 
Considering the clinical, SPECT, and laboratory findings in our patients, a migrainelike 
mechanism may be proposed. Clinical symptomatology includes transient development 
of confusion, agitation, seizures, and transient cortical blindness followed by reversible 
neuropsychologic deficits. Patients 1 and 2 recovered spontaneously within a few days 
from all clinical symptoms and from alterations detected by morphologic and functional 
neuroimaging. Patient 3 also recovered rapidly, but a residual reading disorder took 2 
months to resolve completely. This clinical symptomatology is similar to that seen in 
patients with complicated migraine [7]. Thus we think that this type of transient acute 
encephalopathy may be due to a similar brain disorder. 
 
The posterior brain region hypoperfusion demonstrated by SPECT in Patients 1 and 2 
also supports this migrainelike theory. Others also have been able to describe 
hypoperfusion with SPECT during the aura phase of the migraine, mainly in parieto-
occipital regions [8]. On the contrary, hyperperfusion has been found with SPECT in 
hypertensive encephalopathy [6]. 
 
The present theory about the pathophysiology of the migraine aura is based on the 
cortical spreading depression (CSD) phenomenon, which is thought to be responsible 
for the negative neurologic symptoms [9]. The CSD is a short-lasting depolarization 
wave that moves across the cortex provoking a prolonged nerve cell depression. The 
hypoperfusion that has been demonstrated by SPECT is thought to be a secondary event 
because of the involvement of arterioles in the homeostatic brain changes occurring 
during the spreading depression [9]. 
 
The initiating and underlying causes of the CSD are not yet fully understood. It is 
known that glutamate can trigger CSD by activating N-methyl-D-aspartate receptors and 
that low brain magnesium strongly facilitates the elicitation of CSD in vitro. For this 
reason, the laboratory finding of low magnesium serum levels in the patients reported 
here may also support the migrainelike mechanism for this posterior encephalopathy. 
Several studies have reported low levels of plasma total and ionized magnesium during 
and between migraine attacks, so an imbalance in the Ca2+/ Mg2+ ratio has been 
postulated as a triggering mechanism of transient vasomotor instability [10,11]. 
Therapeutic trials with magnesium sulfate have been successful in diminishing the 
frequency of cephalalgic episodes and in aborting attacks [12,13]. In all three patients, 
total magnesium plasma levels were below normal limits. Hypomagnesemia occurs 
frequently during cancer chemotherapy y; MTX in association with cyclophosphamide 
or iphosphamide causes a renal tubulopathy that leads to Mg2+ loss in 70% of patients 
[14]. 
 
Neither previous episodes of severe intermittent headache that could be diagnosed as 
migraine nor family history of migraine were reported by our patients. Family 
predisposition is not, therefore, likely to be a triggering mechanism of the episodes in 
these three patients. Therefore low magnesium serum levels could be a trigger instead. 
As suggested by Hinchey et al. [1] a vascular instability resulting from the toxicity of 
the chemotherapy agents on the endothelium of the blood-brain barrier can also be 
contributing. A multifactorial origin of the disorder is more likely because not every 
patient with low magnesium serum levels while receiving chemotherapy develops this 
encephalopathy. 
 
Other theories have been proposed to explain the physiopathology of this acute 
posterior encephalopathy. Micrometastasis or necrotic tissue embolisms from lungs are 
not probable because of the transient symptoms and the absence of lung metastasis in all 
of the cases reported here and by others [15]. 
 
In the literature, this acute posterior encephalopathy most frequently is associated with 
HDMTX treatments. However, it is not clear which drug was responsible in the cases 
reported here. HDMTX had been administered 1 week before the episodes in Patients 2 
and 3, but it had not been given for 1 month, because of toxicity, in Patient 1. The three 
patients had also received cyclophosphamide and dactynomycin within the few days 
preceding the neurologic complication. 
 
In conclusion, clinical, neuroimaging, and laboratory observations support the 
hypothesis that a migrainelike mechanism underlies this acute encephalopathic 
syndrome sometimes observed during aggressive chemotherapy. If sudden-onset 
neurologic deficits arise and brain hemorrhage, central nervous system infection, and 
hydroelectrolytic disturbances have been excluded, this posterior encephalopathy can be 
diagnosed. Arterial hypertension may be a precipitant in some cases together with 
endothelium brain barrier damage; however, Ca2+/Mg2+ imbalance is probably the most 
important trigger of vasomotor instability and of the CSD phenomenon. Oral 
magnesium prophylaxis is a common practice in patients receiving chemotherapy, but 
anorexia and/or vomiting sometimes make it impossible to achieve normal serum levels. 
Calcium channel antagonists and magnesium sulphate, perhaps in addition to 
corticosteroids for brain edema and other antihypertensive agents if needed, might 
shorten the symptomatic period. 
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Figure 1. (A) 99mTc-HmPAO SPECT of Patient 1 during the acute stage demonstrating 
hypoperfusion in right hemisphere, predominantly in white matter, but also affecting 
gray matter in the parieto-occipital area. (B) 99mTc-HmPAO SPECT 36 hours after the 
acute episode revealed normal perfusion. 
 
 
 
 
 
Figure 2. MRI brain scan findings of Patient 3. Axial T2-weighted image demonstrates 
hyperintense signal involving parieto-temporo-occipital areas (T2 3500/93/1 
(TR/TE/ADQ). FOV: 250. Matrix: 192 x 256. Thickness: 5 mm. 1 T). 
